A surprising no to both multiple myeloma uses puts the ball in the FDA's court.
ApexOnco Front Page
Recent articles
17 July 2025
The group has canned its first-generation project, hoping that a follow-on will reach more patients.
9 April 2025
Golcadomide will begin a new pivotal trial in follicular lymphoma.
9 April 2025
Against the odds, the CD47 inhibitor now faces two more clinical catalysts.
4 April 2025
Can the company add a Car-T string to its stem cell transplant bow?
3 April 2025
After failure of its second-line trial to show an OS benefit, the pressure is on in the front line.
3 April 2025
The first-line Destiny-Gastric05 trial includes a PD-L1-negative cohort.